SEC Form 4 · accession 0000899243-18-002757
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P Bailey
Officer — President & CEO · Director
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 8:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.08 | Feb 1, 2018 | A | 1,000,000 | A | — | Feb 1, 2028 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal monthly installments from February 1, 2018, through February 1, 2022, subject to the Reporting Person's continued service to the Company.